Soaring Eagle Acquisition Corp

Soaring Eagle Acquisition Corp. is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on October 22, 2020 and is headquartered in Los Angeles, CA. Redemption Price: 10.04. Warrant Coverage: 1/5.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. It operates through the Cell Programming/Foundry, and Biosecurity segments. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

The Special Purpose Acquisition Company (SPAC) begins trading publicly. During this phase the SPAC looks for a target company to merge with or acquire.

SEARCHING PHASE

The SPAC announces which company it will be acquiring (and taking public).

PREVIOUS PHASE

Investors and shareholders will meet to approve the acquisition.

CURRENT PHASE

ARK Genomic Revolution Multi-Sector ETF

One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought over 4.1 million shares of Soaring Eagle Acquisition Corp.

Cathie Wood's ARK Invest Buys Over 4.1 Million Shares of This Biotech-Focused SPAC

BOSTON and EMERYVILLE, Calif., Aug 5, 2021 /PRNewswire/ -- Bolt Threads , a biotechnology company creating the next generation of advanced materials, and Ginkgo Bioworks , Inc. ("Ginkgo"), which is building the leading horizontal platform for cell programming, today announced a partnership.

Bolt Threads to Leverage Ginkgo Bioworks' Platform for Commercial Strain Optimization of b-silk™ Protein

BOSTON, Aug. 3, 2021 /PRNewswire/ -- Ginkgo Bioworks , Inc. ("Ginkgo") today announced that Reshma Kewalramani, M.D., FASN, Chief Executive Officer and President at Vertex, will join its board of directors.

Vertex CEO Reshma Kewalramani, MD to join Ginkgo Bioworks Board of Directors

Ginkgo Bioworks, Inc. and Soaring Eagle Acquisition Corp., a special purpose acquisition company, have announced their $17B merger transaction will finalize in Q3'21 resulting in Ginkgo earning a $15B EV. Ginkgo Bioworks is a high-growth analytical biotechnology company applying automation for contract-based cell engineering utilizing a combination of computational and synthetic biological practices.

Soaring Eagle: SPAC Merger With Promising Synthetic Biology Specialist, Ginkgo Bioworks

Agilon Health

Coupang

Marqeta

Oatly

Playtika Holding

Shoals Technologies Group

Only a select few companies raised at least $1 billion from their IPOs in the first six months of 2021. Here are seven of the best.

7 Jumbo IPOs to Put on Your Must-Buy Stocks List for 2021

BOSTON, May 24, 2021 /PRNewswire/ -- Ginkgo Bioworks, Inc. ("Ginkgo"), which is building the leading horizontal platform for cell programming, today announced that it will hold a virtual Investor Day on Thursday, June 24, 2021, beginning at 1:00pm ET. The Investor Day will feature conversations with Ginkgo's Founders, a virtual Foundry Tour, presentations by Ginkgo senior management, and a showcase of customer programs.

Ginkgo Bioworks Announces Investor Day and Participation in Upcoming Investor Conferences

COVA Acquisition Corp

The De-SPAC ETF

Forest Road Acquisition Corp.

Omnichannel Acquisition Corp.

Seaport Global Acquisition Corp

The Short De-SPAC ETF

TPG Pace Beneficial Finance Corp.

DPCM Capital, Inc.

Last week featured three announced SPAC deals. The week also had earnings from several well-known former SPACs.

'SPACs Attack' Recap: Looking Back At 3 SPAC Deals, SPAC Rumors And The Latest SPAC Headlines And Earnings

Ginkgo Bioworks isn't letting any grass grow under its feet. Just a week after inking a $2.5 billion pact to go public via the special purpose acquisition company Soaring Eagle Acquisition Corp. ( SRNG , Financial), the Boston-based company is expanding overseas.

Ginkgo Bioworks Goes International Days After SPAC Announcement

Hennessy Capital Investment Corp V

Aurora Acquisition Corp

Star Peak Corp II

Centricus Acquisition Corp

Last week featured eight announced SPAC deals. The week also had earnings from several well-known former SPACs.

'SPACs Attack' Recap: Looking Back At 8 SPAC Deals Plus Latest SPAC Headlines And Earnings

Soaring Eagle Acquisition has announced a deal to take Ginkgo Bioworks public in a massive SPAC merger with a pre-money equity valuation of $15 billion. Ginkgo Bioworks is a disruptive biotech company that is pioneering its platform for cell programming.

Soaring Eagle: Meeting Ginkgo, One Of The Most Exciting SPAC Deals Yet

Ginkgo Bioworks is promising a future that's grown rather than built.

Ginkgo's $17.5 Bln SPAC Deal Presupposes Success

A well seasoned SPAC management team announced a SPAC deal Tuesday to bring a cell programming company public. The SPAC Deal: Ginkgo Bioworks is going public in a SPAC deal with Soaring Eagle Acquisition Corp (NASDAQ: SRNG) that values the company at a pre money equity value of $15 billion.

What Investors Should Know About Ginkgo Bioworks SPAC Deal: 'Cell Programming Has The Potential To Impact Every Physical Goods Industry'

Ginkgo Bioworks, a biotech company based in Boston, announced that it will go public via a merger with Soaring Eagle Acquisition Corp. (SRNG), a special purpose acquisition vehicle (SPAC), in a deal that gives the company a pre-money equity valuation of $15 billion. The company expects to receive proceeds of $2.5 billion as part of […] The post Ginkgo Bioworks to go public in a $15B SPAC deal appeared first on Invezz.

Ginkgo Bioworks to go public in a $15B SPAC deal

Ginkgo Bioworks is going public via a merger with former MGM CEO Harry Sloan's SPAC in a deal that values the biotech company at $15 billion.

Bill Gates-backed Ginkgo Bioworks going public via $15 billion SPAC

BOSTON and LOS ANGELES, May 11, 2021 /PRNewswire/ -- Business combination with Soaring Eagle Acquisition Corp. (Nasdaq:SRNG) values Ginkgo Bioworks, Inc. at a $15 billion pre-money equity valuation and is expected to provide up to $2.5 billion of primary proceeds. Institutional investors have committed $775 million in an oversubscribed PIPE, with anchor investments from Baillie Gifford, Putnam Investments, and funds and accounts managed by Counterpoint Global (Morgan Stanley Investment Management).

Ginkgo Bioworks to Become a Public Company and Expand its Leading Platform for Cell Programming

News for Soaring Eagle Acquisition Corp Stock (SRNG)